Skip to main content

Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.

Deleu J, Schoofs K, Decock A, Verniers K, Roelandt S, Denolf A, Verreth J, De Wilde B, Van Maerken T, De Preter K, Vandesompele J

Publication: Hum Genomics (2022) • Vol 16 • Page 73PMID: 36587211View on PubMed

Purpose

The purpose of this paper was to compare cell-free DNA (cfDNA) and cell-free RNA (cfRNA) yields obtained from citrate and EDTA plasma of healthy volunteers using six different co-isolation methods. The effects of plasma volume on cfDNA and cfRNA yield and eluate volume on digital PCR amplification were also investigated.

Conclusion

cfDNA and cfRNA yields increased with as plasma input volume increased (0.06-4 mL), regardless of extraction method, but there was little variation between EDTA and citrate plasma and among donors.  The highest cfRNA and cfDBA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit; however, the eluate volume from the iCatcher Circulating cfDNA/cfRNA 4000 Kit was highly variable. When the volume of eluate that was used as input for real-time PCR amplification was increased (from 10% to 40% of the reaction volume), amplification increased accordingly indicating the absence of PCR inhibitors. Importantly, the ability to increase input volume without introducing PCR inhibition permitted an increase in sensitivity. Intriguingly, when cfDNA and cfRNA were co-purified from the plasma of three healthy volunteers using the miRNeasy Serum/Plasma Advanced Kit, the sum of the separately measured cfDNA and cfRNA concentrations was lower than the jointly measured concentration.

 

Studies (1)

Purpose

The purpose of this study was to compare cfDNA and cfRNA yields obtained from citrate and EDTA plasma of healthy volunteers using six different co-isolation methods. The effects of plasma volume on cfDNA and cfRNA yield and eluate volume on digital PCR amplification were also investigated. Blood was collected from three healthy volunteers into EDTA and citrate tubes. Plasma was isolated by centrifugation (twice at 2500 x g for 15 min) and then stored at -80°C. cfDNA and cfRNA were coextracted from 0.06-4 mL of plasma using the miRNeasy Serum/Plasma Advanced Kit, QIAamp ccfDNA/RNA Kit, iCatcher Circulating cfDNA/cfRNA 4000 kit, MagNA Pure 24 Total NA Isolation Kit, Maxwell ccfDNALV Plasma Kit, and the miRNeasy Serum/Plasma Kit. Isolated cfDNA and cfRNA were stored at -80°C. DNA was removed from cfRNA by DNase treatment and reverse transcribed using the iScript Advanced cDNA Synthesis Kit. cfDNA and cfRNA were quantified by the same duplex digital PCR assays amplifying CAVIN2/NRGN and AIF1/B2M. Total cfDNA and cfRNA were quantified together using the same digital PCR assays to amplify cDNA from cfRNA that was not DNase-treated and thus still contained  cfDNA.  cfDNA fragment size was analyzed using a TapeStation instrument.

Summary of Findings

cfDNA and cfRNA yields increased as plasma input volume increased (0.06-4 mL), regardless of extraction method, and there was little variation between EDTA and citrate plasma and among donors.  The eluate volume from the iCatcher Circulating cfDNA/cfRNA 4000 Kit was highly variable (18-27 µL), but the eluate volume with the other kits was reproducible. Nevertheless, the highest cfRNA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit. Similarly, the highest cfDNA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit and the single strand protocol of the MagNA Pure 24 Total NA Isolation Kit. Overall, the percentage of isolated DNA that was ~170 bp ranged from 64-94%, indicating that all kits successfully isolated cfDNA.  When the volume of eluate that was used as input for real-time PCR amplification was increased (from 10% to 40% of the reaction volume),,  amplification increased accordingly indicating the absence of PCR inhibitors. Importantly, the ability to increase input volume without PCR inhibition permitted an increase in sensitivity. Intriguingly, when cfDNA and cfRNA were co-purified from the plasma of three healthy volunteers using the miRNeasy Serum/Plasma Advanced Kit, the sum of the separately measured cfDNA and cfRNA concentrations was lower than the jointly measured concentration. The authors state this may be attributable a negative effect of the DNAse treatment step on cfRNA concentration or that cDNA synthesis increases cfDNA quantification.  

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    DNAAutomated electrophoresis/Bioanalyzer
    DNADigital PCR
    RNADigital PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate
    EDTA
    Biospecimen Aliquots and ComponentsAliquot size/volume
    0.06 mL plasma
    0.2 mL plasma
    0.6 mL plasma
    1.0 mL plasma
    2.0 mL plasma
    4.0 mL plasma
    Analyte Extraction and PurificationAnalyte isolation method
    MagNA Pure 24 Total NA Isolation Kit
    Maxwell ccfDNALV Plasma Kit
    QIAamp ccfDNA/RNA Kit
    iCatcher Circulating cfDNA/cfRNA 4000 kit
    miRNeasy Serum/Plasma Advanced Kit
    miRNeasy Serum/Plasma Kit
    Digital PCR SpecificTargeted nucleic acid
    AIF1/B2M
    CAVIN2/NRGN
    Digital PCR SpecificTemplate/input amount
    10% of reaction volume
    20% of reaction volume
    30% of reaction volume
    40% of reaction volume